Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (31-40 of 337) with videos related to

Pageof 34
Sort By:
F1000Research|February 25, 2021
Patient-centered benefit-risk analysis of transcatheter aortic valve replacementKevin Marsh, Natalia Hawken, Ella Brookes, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Challenges in Conducting Quantitative Patient-Centered Benefit-Risk Assessments: A Case Study in Ph + ALL with Immature Efficacy DataAjibade Ashaye, Caitlin Thomas, Vamsi Kota, et al.
Lancet (London, England)|May 21, 2016
Mind the gap: jumping from vaccine licensure to routine useKatherine L O'Brien, Fred Binka, Kevin Marsh, et al.
Nature Immunology|June 20, 2008
Immunity to malaria: more questions than answersJean Langhorne, Francis M Ndungu, Anne-Marit Sponaas, et al.
The Patient|January 25, 2024
Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice ExperimentHannah Collacott, Andrea Phillips-Beyer, Nicolas Krucien, et al.
Malaria Journal|June 30, 2007
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-lifeSamson M Kinyanjui, David J Conway, David E Lanar, et al.
AAS Open Research|March 12, 2021
Funding and COVID-19 research priorities - are the research needs for Africa being met?Emilia Antonio, Moses Alobo, Marta Tufet Bayona, et al.
International Journal of Technology Assessment in Health Care|December 27, 2017
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCESKevin Marsh, J Jaime Caro, Erica Zaiser, et al.
Health Economics Review|September 5, 2012
Estimating cost-effectiveness in public health: a summary of modelling and valuation methodsKevin Marsh, Ceri J Phillips, Richard Fordham, et al.
The Journal of Infectious Diseases|July 23, 2002
Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in KenyaJ Anthony G Scott, Jacktone Obiero, Andrew J Hall, et al.
Pageof 34

Showing results (31-40 of 337) with videos related to

Sort By:
Pageof 34
F1000Research|February 25, 2021
Patient-centered benefit-risk analysis of transcatheter aortic valve replacementKevin Marsh, Natalia Hawken, Ella Brookes, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Challenges in Conducting Quantitative Patient-Centered Benefit-Risk Assessments: A Case Study in Ph + ALL with Immature Efficacy DataAjibade Ashaye, Caitlin Thomas, Vamsi Kota, et al.
Lancet (London, England)|May 21, 2016
Mind the gap: jumping from vaccine licensure to routine useKatherine L O'Brien, Fred Binka, Kevin Marsh, et al.
Nature Immunology|June 20, 2008
Immunity to malaria: more questions than answersJean Langhorne, Francis M Ndungu, Anne-Marit Sponaas, et al.
The Patient|January 25, 2024
Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice ExperimentHannah Collacott, Andrea Phillips-Beyer, Nicolas Krucien, et al.
Malaria Journal|June 30, 2007
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-lifeSamson M Kinyanjui, David J Conway, David E Lanar, et al.
AAS Open Research|March 12, 2021
Funding and COVID-19 research priorities - are the research needs for Africa being met?Emilia Antonio, Moses Alobo, Marta Tufet Bayona, et al.
International Journal of Technology Assessment in Health Care|December 27, 2017
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCESKevin Marsh, J Jaime Caro, Erica Zaiser, et al.
Health Economics Review|September 5, 2012
Estimating cost-effectiveness in public health: a summary of modelling and valuation methodsKevin Marsh, Ceri J Phillips, Richard Fordham, et al.
The Journal of Infectious Diseases|July 23, 2002
Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in KenyaJ Anthony G Scott, Jacktone Obiero, Andrew J Hall, et al.
Pageof 34